The DOI matches its Crossref record; 271 of the 271 references it cites were found in a registry or an index.
Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness
Open accessAbstract
Triple-negative breast cancer (TNBC) is cancer that tested as negative for estrogen receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor receptor 2 (HER2) protein which accounts for 15%–20% of all breast cancer cases. TNBC is considered to be a poorer prognosis than other types of breast cancer, mainly because it involves more aggressive phenotypes that are similar to stem cell–like cancer cells (cancer stem cell, CSC). Thus, targeted treatment of TNBC remains a major challenge in clinical practice. This review article surveys the latest evidence concerning the role of genomic alteration in current TNBC treatment responses, current clinical trials and potential targeting sites, CSC and drug resistance, and potential strategies targeting CSCs in TNBC. Furthermore, the role of insulin-like growth factor 1 receptor (IGF-1R) and nicotinic acetylcholine receptors (nAChR) in stemness expression, chemoresistance, and metastasis in TNBC and their relevance to potential treatments are also discussed and highlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–271 of 271
Oncologic Trogocytosis of an Original Stromal Cells Induces Chemoresistance of Ovarian Tumours
Rafii, A., Mirshahi, P., Poupot, M., Faussat, A., Simon, A., Ducros, E., Mery-Lamarche, E., Couderc, B. C., Lis, R., Capdet, J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003894 · Cited by 119
Chang, W., Lin, R., Yu, J., Chang, W., Fu, C.-H., Lai, A. C., Yu, A. L.-T., & Yu, A. L.-T. (2013) · Breast Cancer Research · doi:10.1186/bcr3423 · Cited by 119
Bell, R., Brown, J. M., Parmar, M., Toi, M., Suter, T. M., Steger, G. G., Pivot, X. B., Mackey, J. R., Jackisch, C., Dent, R. A., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw665 · Cited by 118
Sun, R., Shen, S., Zhang, Y., Xu, C., Cao, Z., Wen, L., & Wang, J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.038 · Cited by 116
Tumor Cells Upregulate Normoxic HIF-1α in Response to Doxorubicin
Cao, Y., Eble, J. M., Moon, E., Yuan, H., Weitzel, D. H., Landon, C. D., Yu-Chih Nien, C., Hanna, G., Rich, J. N., Provenzale, J. M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1345 · Cited by 111 · cited 1×
“For example, expression can be induced by treatment of breast cancer cells with doxorubicin under normoxic environments [120].”
BackgroundHo, Y., CHEN, C., Wang, Y., Pestell, R. G., ALBANESE, C., Chen, R., Chang, M., Jeng, J., Lin, S., & Liang, Y. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.09.019 · Cited by 110
Self-citationKrasnov, G. S., Dmitriev, A. A., Snezhkina, A. V., & Kudryavtseva, A. V. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.775253 · Cited by 108
Yamamoto, Y., Yoshioka, Y., Minoura, K., Takahashi, R., Takeshita, F., Taya, T., Horii, R., Fukuoka, Y., Kato, T., Kosaka, N., et al. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-135 · Cited by 108
Autophagy maintains the stemness of ovarian cancer stem cells by FOXA2.
Peng, Q., Qin, J., Zhang, Y., Cheng, X., Wang, X., Lü, W., Xie, X., & Zhang, S. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0644-8 · Cited by 104
Lee, C., Chang, Y.-C., Chen, C.-S., Tu, S., Wang, Y., Chen, L.-C., Chang, Y., Wei, P., Chang, H.-W., Chang, C.-H., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1209-0 · Cited by 103
Self-citationThe IGF Hormonal Network in Endometrial Cancer: Functions, Regulation, and Targeting Approaches
Bruchim, I., Sarfstein, R., & Werner, H. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00076 · Cited by 98
Chang, C.-H., Zhang, M., Rajapakshe, K., Coarfa, C., Edwards, D. P., Huang, S., & Rosen, J. M. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.07.009 · Cited by 97
Moon, C. M., Kwon, J., Kim, J. S., Oh, S., Lee, K. J., Park, J. J., Hong, S. P., Cheon, J. H., Kim, T. I., & Kim, W. H. (2013) · International Journal of Cancer · doi:10.1002/ijc.28381 · Cited by 96
Self-citationThe role of insulin and IGF system in pancreatic cancer
Trajkovic‐Arsic, M., Kalideris, E., & Siveke, J. T. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0259 · Cited by 96
Chang, T., Wu, Y.-C., Chi, C., Su, W.-C., Chang, P., Lee, K.-F., Tung, T.-H., Wang, J., Liu, J., Tung, S., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3274 · Cited by 94
Self-citationZhu, L., Hu, Y., Yang, C., Xu, X., Ning, T., Wang, Z., Ye, J., & Liu, L. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.8 · Cited by 93
ALDH1A1 overexpression is associated with the progression and prognosis in gastric cancer
Li, X.-S., Xu, Q. R., Fu, X., & Luo, W. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-705 · Cited by 90
Chaterjee, M., & van Golen, K. L. (2011) · Bone Marrow Research · doi:10.1155/2011/362938 · Cited by 88
Hawley, T. S., Riz, I., Yang, W., Wakabayashi, Y., DePalma, L., Chang, Y., Peng, W., Zhu, J., & Hawley, R. G. (2013) · American Journal of Hematology · doi:10.1002/ajh.23387 · Cited by 87
Guha, P., Bandyopadhyaya, G., Polumuri, S. K., Chumsri, S., Gade, P., Kalvakolanu, D. V., & Ahmed, H. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2912-z · Cited by 80
Cucina, A., Dinicola, S., Coluccia, P., Proietti, S., D’Anselmi, F., Pasqualato, A., & Bizzarri, M. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2011.12.029 · Cited by 79
Marcucci, F., Ghezzi, P., & Rumio, C. (2017) · Molecular Cancer · doi:10.1186/s12943-016-0573-8 · Cited by 79
Lipid Raft-Mediated Regulation of Hyaluronan–CD44 Interactions in Inflammation and Cancer
Murai, T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00420 · Cited by 78
Wei, P., Chang, Y., Ho, Y., Lee, C., Yang, Y.-Y., An, J., & Lin, S.-Y. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181a6ce7e · Cited by 78
Self-citationTrevino, J. G., Pillai, S., Kunigal, S., Singh, S., Fulp, W. J., Centeno, B. A., & Chellappan, S. (2012) · Neoplasia · doi:10.1593/neo.121044 · Cited by 77
Chen, R.-J., Ho, Y., Guo, H., & Wang, Y. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq028 · Cited by 75
Self-citationGautam, P., Karhinen, L., Szwajda, A., Jha, S. K., Yadav, B., Aittokallio, T. A., & Wennerberg, K. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0517-3 · Cited by 74
Ovarian tumor-initiating cells display a flexible metabolism
Anderson, A. S., Roberts, P. C., Frisard, M. I., Hulver, M. W., & Schmelz, E. M. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.08.028 · Cited by 73
Implications of cancer stem cells in developing therapeutic resistance in oral cancer
Naik, P. P., Das, D. N., Panda, P. K., Mukhopadhyay, S., Sinha, N., Praharaj, P. P., Agarwal, R., & Bhutia, S. K. (2016) · Oral Oncology · doi:10.1016/j.oraloncology.2016.10.008 · Cited by 72
Effect of ALDH1 on prognosis and chemoresistance by breast cancer subtype
Kida, K., Ishikawa, T., Yamada, A., Shimada, K., Narui, K., Sugae, S., Shimizu, D., Tanabe, M., Sasaki, T., Ichikawa, Y., et al. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3738-7 · Cited by 71
Li, B., Tsao, S. W., Chan, K. W., Ludwig, D. L., Novosyadlyy, R., Li, Y. Y., He, Q., & Cheung, A. L. M. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2735 · Cited by 70
Doxycycline induces apoptosis in PANC-1 pancreatic cancer cells.
Son, K., Fujioka, S., Iida, T., Furukawa, K., Fujita, T., Yamada, H., Chiao, P. J., & Yanaga, K. K. (2009) · PubMed · Cited by 69
Autocrine IGF1 Signaling Mediates Pancreatic Tumor Cell Dormancy in the Absence of Oncogenic Drivers
Rajbhandari, N., Lin, W.-C., Wehde, B. L., Triplett, A. A., & Wagner, K.-U. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.013 · Cited by 68
Huang, H., Song, J., Liu, Z., Li, P., & Xu, G. (2017) · Oncology Letters · doi:10.3892/ol.2017.7446 · Cited by 68
Prado-Vázquez, G., Gámez‐Pozo, A., Trilla‐Fuertes, L., Arevalillo, J. M., Zapater‐Moros, A., Ferrer-Gómez, M., Díaz‐Almirón, M., López‐Vacas, R., Navarro, H., Maín, P., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-38364-y · Cited by 67
Francesco, E. M. D., Maggiolini, M., Tanowitz, H. B., Sotgia, F., & Lisanti, M. P. (2017) · Oncotarget · doi:10.18632/oncotarget.18445 · Cited by 67
Yu, C., & Chang, Y. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.11.023 · Cited by 65
Jovanović, B., Beeler, J. S., Pickup, M. W., Chytil, A., Gorska, A. E., Ashby, W. J., Lehmann, B. D., Zijlstra, A., Pietenpol, J. A., & Moses, H. L. (2014) · Breast Cancer Research · doi:10.1186/bcr3684 · Cited by 65
Nishioka, T., Kim, H., Luo, L.-Y., Huang, Y., Guo, J., & Chen, C. Y. (2011) · Breast Cancer Research · doi:10.1186/bcr3055 · Cited by 65
Self-citationSolzak, J. P., Atale, R. V., Hancock, B. A., Sinn, A. L., Pollok, K. E., Jones, D. R., & Radovich, M. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0016-8 · Cited by 64
Serafino, A., Zonfrillo, M., Andreola, F., et al. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911795655976 · Cited by 63
Yan, Y., Li, Z., Xu, X. D., Chen, C., Wei, W., Fan, M., Chen, X., Li, J. J., Wang, Y., & Huang, J. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1088-y · Cited by 63
Moreira, M. P., Braga, L. D. C., Cassali, G. D., & Silva, L. M. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.01.018 · Cited by 61
Li, Z., Ying, X., Chen, H.-L., Ye, P.-J., Chen, Z., Li, G., Jiang, H.-F., Liu, J., & Zhou, S. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i43.7788 · Cited by 60
Yang, W. V., Chen, H., Au, H., Chang, C.-W., Huang, C.-T., Yen, Y.-H., & Tzeng, C. (2004) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2004.03.003 · Cited by 58
Lien, Y.-C., Wang, W., Kuo, L., Liu, J., Wei, P., Ho, Y., Ting, W.-C., Wu, C., & Chang, Y. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1598-2 · Cited by 58
Self-citationSingh, R. K., Gaikwad, S. M., Jinager, A., Chaudhury, S., Maheshwari, A., & Ray, P. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.08.023 · Cited by 57
Nicotine increases cancer stem cell population in MCF-7 cells
Hirata, N., Sekino, Y., & Kanda, Y. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.134 · Cited by 56
Palma, J. P., Rodriguez, L. E., Bontcheva-Diaz, V., Bouska, J. J., Bukofzer, G. T., Colón-López, M. S., Guan, R., Jarvis, K., Johnson, E. F., Klinghofer, V., et al. (2008) · PubMed · Cited by 56
Defective autophagy leads to the suppression of stem-like features of CD271+ osteosarcoma cells
Zhang, D., Zhao, Q., Sun, H., Yin, L., Wu, J., Xu, J., He, T., Yang, C., & Liang, C. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0297-5 · Cited by 55
The roles of BECN1 and autophagy in cancer are context dependent
Gong, C., Song, E., Codogno, P., & Mehrpour, M. (2012) · Autophagy · doi:10.4161/auto.21996 · Cited by 49
Cao, Y., Lindström, S., Schumacher, F. R., Stevens, V. L., Albanes, D., Berndt, S. I., Boeing, H., Bueno-de-Mesquita, H. B., Canzian, F., Chamosa, S., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju085 · Cited by 48
Nicotine increases survival in human colon cancer cells treated with chemotherapeutic drugs
Dinicola, S., Morini, V., Coluccia, P., Proietti, S., D’Anselmi, F., Pasqualato, A., Masiello, M. G., Palombo, A., Toma, G. D., Bizzarri, M., et al. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.09.020 · Cited by 47
Chang, T., Chen, C., Wu, Y.-C., Liu, J., Kuo, Y., Lee, K.-F., Lin, S.-Y., Lin, S., Tung, S., Kuo, L.-M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149897 · Cited by 47
Self-citationCirculating IGF system and treatment outcome in epithelial ovarian cancer
Huang, Y.-F., Cheng, W., Wu, Y.-P., Cheng, Y.-M., Hsu, K., & Chou, C.-Y. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0274 · Cited by 46
Self-citationGautam, P., Jaiswal, A., Aittokallio, T. A., Al‐Ali, H., & Wennerberg, K. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2019.03.011 · Cited by 46
Valverde, A. M., Peñarando, J., Cañas, A., Lopez-Sanchez, L. M., Conde, F., Hernandez, V. A., Peralbo, E., López-Pedrera, C., de la Haba-Rodríguez, J., Aranda, E., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131363 · Cited by 43
TGF-βI Regulates Cell Migration through Pluripotent Transcription Factor OCT4 in Endometriosis
Au, H., Chang, J.-H., Wu, Y.-C., Kuo, Y., Chen, Y.-H., Lee, W.-C., Chang, T., Lan, P., Kuo, H.-C., Lee, K., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145256 · Cited by 41
Self-citationKuo, Y., Au, H., Hsu, J., Wang, H.-F., Lee, C.-J., Peng, S.-W., Lai, S.-C., Wu, Y.-C., Ho, H., & Huang, Y. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.12.003 · Cited by 38
Self-citationReactive oxygen species and aldehyde dehydrogenase activity in Hodgkin lymphoma cells
Ikeda, J.-I., Mamat, S., Tian, T., Wang, Y., Luo, W., Rahadiani, N., Aozasa, K., & Morii, E. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.4 · Cited by 37
An active IGF-1R-AKT signaling imparts functional heterogeneity in ovarian CSC population
Singh, R. K., Dhadve, A., Sakpal, A., De, A., & Ray, P. (2016) · Scientific Reports · doi:10.1038/srep36612 · Cited by 36
Gasparetto, M., & Smith, C. A. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.06.020 · Cited by 36
Wang, W., Hung, C., Kuo, L., Wei, P., Lien, Y.-C., Lin, F., Liu, H.-H., Ho, Y., Wu, C., & Chang, Y. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2064-x · Cited by 35
Self-citationKuo, C.-N., Pan, J., Huang, Y.-W., Tsai, H., & Chang, W. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0876 · Cited by 34
Self-citationThe dynamics of cancer stem cells
Hatina, J. (2012) · Neoplasma · doi:10.4149/neo_2012_092 · Cited by 33
Rethinking Extended Adjuvant Antiestrogen Therapy to Increase Survivorship in Breast Cancer
Abderrahman, B., & Jordan, V. C. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3510 · Cited by 32
Cao, Y., Lindström, S., Schumacher, F. R., Stevens, V. L., Albanes, D., Berndt, S. I., Boeing, H., Bueno-de-Mesquita, H. B., Canzian, F., Chamosa, S., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju218 · Cited by 32
Huang, Y.-H., Lin, M. H., Wang, P.-C., Wu, Y.-C., Chiang, H.-L., Wang, Y., Chang, J. H., Huang, Y., Gu, S.-Y., Ho, H., et al. (2014) · Molecular Human Reproduction · doi:10.1093/molehr/gau016 · Cited by 21
Self-citationTentori, L., Muzi, A., Dorio, A. S., Scarsella, M., Leonetti, C., Shah, G. M., Xu, W., Camaioni, E., Gold, B. I., Pellicciari, R., et al. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910791208571 · Cited by 18
CHRNA9 polymorphisms and smoking exposure synergize to increase the risk of breast cancer in Taiwan
Hsieh, Y., Lee, C., Tu, S., Wu, C., Hung, C., Hsieh, M.-C., Chuang, C.-W., Ho, Y., & Chiou, H. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu179 · Cited by 17
Self-citationKubasiak, J., Seder, C. W., Pithadia, R., et al. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.08.085 · Cited by 15
Metadata
- Authors
- Lee, K.-L., Kuo, Y.-C., Ho, Y.-S., & Huang, Y.-H.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2019-09-09
- Volume
- 11
- Issue
- 9
- Pages
- 1334
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W2972270957
- Cited by
- 260
- References
- 271
- FWCI
- 11.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.